Biotectix focuses on the development of bioactive conductive polymer electrodes and coatings for electrodes for medical devices.
Biotectix is a Massachusetts, United States-based biotechnology company engaged in the development of bioactive conductive polymer electrodes and coatings for electrodes for application in medical devices, including glucose sensors, cochlear implants, cortical probes, and more. The company was established by David Martin, Jeff HendricksJeff Hendricks and Sarah Richardson-Burns in 2007 and was acquired by Heraeus on Sep 6, 2017.
Biotectix focuses on the development of bioactive conductive polymer electrodes and coatings for electrodes for medical devices.